Lv1
40 积分 2026-01-18 加入
5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial
2小时前
已完结
Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection plus chemotherapy in HER2-positive early breast cancer (FeDeriCa): a randomised, open-label, multicentre, non-inferiority, phase 3 study
2小时前
已完结
Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection plus chemotherapy in HER2-positive early breast cancer (FeDeriCa): a randomised, open-label, multicentre, non-inferiority, phase 3 study
2小时前
已完结
Adjuvant Pertuzumab and Trastuzumab in Early Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in the APHINITY Trial: Third Interim Overall Survival Analysis With Efficacy Update
2小时前
已完结
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer in the APHINITY Trial: 6 Years' Follow-Up
2小时前
已完结
Treadmill Running Reverses Cognitive Declines due to Alzheimer Disease
20天前
已完结
Oxidative Stress Is a Central Target for Physical Exercise Neuroprotection Against Pathological Brain Aging
20天前
已完结
Conceptualizing “positive attributes” across psychological perspectives
2个月前
已完结
A Pilot Study: PET/CT Cross-Modal-Based Multi-Head Fusion Attention Generative Adversarial Network (MHFA-GAN) for PET Image Super-Resolution
3个月前
已完结
A Pilot Study: PET/CT Cross-Modal-Based Multi-Head Fusion Attention Generative Adversarial Network (MHFA-GAN) for PET Image Super-Resolution
3个月前
已关闭
皖公网安备34019202002308
